This brand name is authorized in Brazil
The drug CLIOQDERM contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Clioquinol
UNII 7BHQ856EJ5 - CLIOQUINOL
|
|
|
|
2
Gentamicin
UNII 8X7386QRLV - GENTAMICIN SULFATE
|
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
|
3
Tolnaftate
UNII 06KB629TKV - TOLNAFTATE
|
|
|
|
4
Betamethasone
UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510417040150003, 510417040150103, 510417040150203, 510417040150303 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
